Leslie Chong is Chief Executive Officer, Director & MD at Imugene Ltd.

She is also on the board of Cure Brain Cancer Foundation and Chimeric Therapeutics Ltd. (Australia).

Ms. Chong previously held the position of Head-Clinical Operation at Exelixis, Inc., Member-Clinical Operation Department at GlaxoSmithKline Plc and Member-Clinical Operation Department at Pharmaceutical Product Development LLC.